Elmiron Maculopathy Vision Loss Lawsuit MDL 2973: Eligibility and Claims Guide 2026
Comprehensive guide to the Elmiron (pentosan polysulfate sodium) pigmentary maculopathy vision loss lawsuit MDL 2973 in New Jersey: Janssen/J&J defendant, ~730 active cases, FDA black box warning June 2020, eligibility criteria, statutes of limitations, and what long-term users need to know.
MDL 2973 Elmiron lawsuit pentosan polysulfate